Industry News
Australia's first Zoobiquity conference coming to Sydney
On 27 February, the University of Sydney will host the first Zoobiquity conference ever to be held outside North America. Zoologists, molecular biologists and human and veterinary physicians will come together as they adopt an interdisciplinary approach to nutrition and disease in humans and animals. [ + ]
Biofuel from rice
A simple farm-based method for producing biofuels and feed for animals. [ + ]
Epigenetic patterns differentiate triple-negative breast cancers
Australian researchers have identified a new method that could help tell the difference between highly aggressive and more benign forms of triple-negative breast cancer (TNBC). [ + ]
Annual industry position survey seeking CEOs' views
AusBiotech calls on leaders of biotechnology companies (CEOs and MDs) to respond to the annual Biotechnology Industry Position Survey 2015, enabling them to contribute to the annual snapshot and build the advocacy platform for the year to come.
[ + ]Combined effect of pollutants studied in the Arctic
Researchers from the Fram Centre in Norway are conducting studies in Arctic waters to determine whether the combined effect of several pollutants could be more severe than the sum of their individual effects. [ + ]
Orthocell picks up US patent for Celgro
Orthocell (ASX:OCC) has been awarded a US patent covering the use of its Celgro collagen bio-scaffold in soft tissue reconstruction applications. [ + ]
Combined effect of pollutants studied in the Arctic
Researchers from the Fram Centre in Norway are conducting studies in Arctic waters to determine whether the combined effect of several pollutants could be more severe than the sum of their individual effects. [ + ]
Goodnow joins Garvan as deputy director
Professor Chris Goodnow has taken up the position of deputy director at the Garvan Institute of Medical Research. [ + ]
New insight into the origins of lung cancer
Researchers at Sydney's Centenary Institute are working to find new insights into the origins of lung cancer, in the hope of creating avenues for personalising patient therapy. [ + ]
Avita enrols first patient for key burns trial
Avita Medical (ASX:AVH) has started recruiting for a phase III trial of ReCell in burn injuries, as part of its application process in the US and by extension the UK.
[ + ]Perform at the Cheltenham Science Festival with FameLab
The British Council has opened the call for applications for FameLab 2015 - a competition for science, maths and engineering researchers with a determination to build their communication skills and make strong connections with others. [ + ]
Perform at the Cheltenham Science Festival with FameLab
The British Council has opened the call for applications for FameLab 2015 - a competition for science, maths and engineering researchers with a determination to build their communication skills and make strong connections with others. [ + ]
ResMed boosts December quarter profit by 5%
Sleep-disordered breathing technology company ResMed (ASX:RMD) has reported a 5% increase in profit and a 10% hike in revenue for the December quarter.
[ + ]Foresight to translate research into treatments, devices and diagnostics
Amid the growing realisation that Australian research needs support to make it a reality, the Queensland Premier has pledged a "centrepiece" $90 million Research to Reality Fund if the LNP is returned in this weekend's election.
[ + ]Manifex to fund commercialisation of high-tech products
Evergreen private investment firm Manifex has opened of its second round of funding to help start-ups commercialise their high-tech products. Funding will be available to support companies that have developed technology in the advanced materials and advanced manufacturing sectors. [ + ]

